GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of is it normal to get early fullness at week 64 — 32 comments in the full submission. View in context.
523
c/retatrutide·submitted 1 year ago by u/lina_bruun

is it normal to get early fullness at week 64

Trial Databranch of 7 comments

Check-in as promised in the title: is it normal to get early fullness at week 64. Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer. Independent purity testing on this compound is thin compared with…

Read the full submission and all 32 comments →

This branch

7 comments, started 1 year ago
u/incretin_ivyMOD75 points·1 year ago

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

replysharereportpermalink
u/yannick_salinas113 points·1 year ago

phase 2 data only, and people quote it like it is a label

replysharereportpermalink
u/emil_wojcik38 points·1 year ago

a lot of the confident posting here is extrapolation

replysharereportpermalink
u/renzo_yildiz95 points·1 year ago

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

replysharereportpermalink
u/arne_amankwah40 points·1 year ago

the escalation is where most of the reported trouble sits

replysharereportpermalink
u/employer_carveout14 points·1 year ago

Sent a vial to Medutest out of curiosity. Result was 99.5% against a claimed 99.0%, which is the first independent number I had seen for this compound anywhere.

replysharereportpermalink
u/marit_laurent6 points·1 year ago

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.